Contact: Kara Gavin
University of Michigan Health System
Caption: Dr. Eva Feldman of the University of Michigan discusses the FDA approval of a Phase II clinical trial of stem cell injections for patients with ALS, also known as Lou Gehrig's disease.
Credit: University of Michigan/Logan6
Usage Restrictions: None
Related news release: FDA approves Phase II of stem cell trial for ALS led by U-M's Dr. Eva Feldman